• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP2C9 和 CYP2A6 对丙戊酸血药浓度的影响:一项荟萃分析。

Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.

机构信息

Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.

College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.

出版信息

Eur J Clin Pharmacol. 2020 Aug;76(8):1053-1058. doi: 10.1007/s00228-020-02872-6. Epub 2020 May 8.

DOI:10.1007/s00228-020-02872-6
PMID:32385545
Abstract

PURPOSE

Cytochrome P450 (CYP) is involved in the metabolism of valproic acid (VPA). Specifically, CYP2C9 and CYP2A6 are the main enzymes responsible for VPA metabolism. However, the correlation between plasma VPA concentrations and CYP2C9 and CYP2A6 gene variations is uncertain. This meta-analysis aimed to investigate the relationship between CYP2C9 and CYP2A6 variants and plasma concentrations of VPA.

METHODS

The PubMed, Web of Science, and EMBASE databases were searched for qualifying studies published until July 2019. Cohort studies that included standardized plasma VPA concentrations and CYP2C9 and CYP2A6 genotypes were reviewed. The mean difference and 95% confidence intervals (CIs) were evaluated to assess the strength of the relationship. Data analysis was performed using Review Manager (version 5.3) and RStudio (version 3.6).

RESULTS

In total, we analyzed data from six studies involving 807 patients. We found that CYP2C9*3 was associated with standardized plasma VPA concentration; 3 allele carriers had a 0.70-μg/mL higher concentration per mg/kg than non-carriers (95% CI 0.25, 1.15; P = 0.002). We also found a significant association between the CYP2A64 and standardized trough VPA concentration; patients with the *4 allele had a 0.48-μg/mL higher concentration per mg/kg than patients without the *4 allele (95% CI 0.10, 0.86; P = 0.01).

CONCLUSION

This meta-analysis demonstrated that CYP2C93 and CYP2A64 genetic variants affect plasma VPA concentrations. For epilepsy patients with these genotypes, dose adjustment may be necessary to ensure VPA's therapeutic effect.

摘要

目的

细胞色素 P450(CYP)参与丙戊酸(VPA)的代谢。具体而言,CYP2C9 和 CYP2A6 是负责 VPA 代谢的主要酶。然而,VPA 血浆浓度与 CYP2C9 和 CYP2A6 基因变异之间的相关性尚不确定。本荟萃分析旨在研究 CYP2C9 和 CYP2A6 变异与 VPA 血浆浓度之间的关系。

方法

检索了 PubMed、Web of Science 和 EMBASE 数据库,以获取截至 2019 年 7 月发表的合格研究。综述了包含标准化 VPA 血浆浓度和 CYP2C9 和 CYP2A6 基因型的队列研究。评估了均数差和 95%置信区间(CI),以评估相关性的强度。使用 Review Manager(版本 5.3)和 RStudio(版本 3.6)进行数据分析。

结果

共分析了来自 6 项研究的 807 例患者的数据。我们发现 CYP2C93 与标准化 VPA 血浆浓度相关;每毫克/千克,携带3 等位基因的患者比非携带者高 0.70-μg/mL(95%CI 0.25, 1.15;P = 0.002)。我们还发现 CYP2A64 与标准化 VPA 谷浓度之间存在显著关联;携带4 等位基因的患者比不携带*4 等位基因的患者高 0.48-μg/mL/毫克/千克(95%CI 0.10, 0.86;P = 0.01)。

结论

本荟萃分析表明,CYP2C93 和 CYP2A64 遗传变异影响 VPA 血浆浓度。对于具有这些基因型的癫痫患者,可能需要调整剂量以确保 VPA 的治疗效果。

相似文献

1
Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.CYP2C9 和 CYP2A6 对丙戊酸血药浓度的影响:一项荟萃分析。
Eur J Clin Pharmacol. 2020 Aug;76(8):1053-1058. doi: 10.1007/s00228-020-02872-6. Epub 2020 May 8.
2
Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.CYP2C9和CYP2A6基因多态性与丙戊酸盐及其肝毒素代谢产物浓度以及丙戊酸盐诱导的肝毒性的相关性。
Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):138-143. doi: 10.1111/bcpt.12776. Epub 2017 May 3.
3
Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.CYP2C9、CYP2A6、ACSM2A和CPT1A基因多态性与丙戊酸对中国癫痫患者不良反应的相关性
Epilepsy Res. 2017 May;132:64-69. doi: 10.1016/j.eplepsyres.2017.02.015. Epub 2017 Feb 27.
4
The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.细胞色素氧化酶CYP2A6、CYP2B6和CYP2C9基因多态性对癫痫患者丙戊酸血药浓度的影响。
Clin Neurol Neurosurg. 2010 May;112(4):320-3. doi: 10.1016/j.clineuro.2010.01.002. Epub 2010 Jan 20.
5
Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.CYP2C19 和 CYP2C9 基因多态性对癫痫患者丙戊酸钠血药浓度的影响。
Eur J Hosp Pharm. 2022 Jul;29(4):198-201. doi: 10.1136/ejhpharm-2020-002367. Epub 2020 Aug 31.
6
Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.影响癫痫患儿丙戊酸血浆浓度的因素及CYP2C9基因分型在丙戊酸个体化治疗中的临床意义
Ther Drug Monit. 2024 Aug 1;46(4):503-511. doi: 10.1097/FTD.0000000000001180. Epub 2024 Jan 26.
7
Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.CYP2C9、CYP2A6和CYP2B6对CYP2C9*1/*1基因型个体肝微粒体中丙戊酸代谢的贡献。
Toxicol Sci. 2006 Dec;94(2):261-71. doi: 10.1093/toxsci/kfl096. Epub 2006 Aug 31.
8
Clinical significance of CYP2C9-status guided valproic acid therapy in children.CYP2C9状态指导下的丙戊酸治疗对儿童的临床意义
Epilepsia. 2015 Jun;56(6):849-55. doi: 10.1111/epi.13011. Epub 2015 May 13.
9
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.年龄、性别及CYP2C9/2C19基因多态性对丙戊酸剂量校正稳态血药浓度的影响——一项基于自然状态下治疗药物监测数据的大规模研究
Eur J Clin Pharmacol. 2016 Sep;72(9):1099-104. doi: 10.1007/s00228-016-2087-0. Epub 2016 Jun 29.
10
Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.尿苷二磷酸葡萄糖醛酸基转移酶2B7 -161C>T基因多态性对小儿癫痫患者丙戊酸浓度的影响。
Ther Drug Monit. 2014 Jun;36(3):406-9. doi: 10.1097/FTD.0000000000000012.

引用本文的文献

1
The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy.候选药物遗传学变异在确定癫痫患者丙戊酸疗效、毒性及血药浓度中的作用
Front Pharmacol. 2024 Oct 30;15:1483723. doi: 10.3389/fphar.2024.1483723. eCollection 2024.
2
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.抗癫痫药物的药物遗传学变异与血药浓度:一项系统评价和荟萃分析。
JAMA Netw Open. 2024 Aug 1;7(8):e2425593. doi: 10.1001/jamanetworkopen.2024.25593.
3
Ethnic Aspects of Valproic Acid P-Oxidation.
丙戊酸P-氧化的种族因素
Biomedicines. 2024 May 8;12(5):1036. doi: 10.3390/biomedicines12051036.
4
Evaluation of Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi.广西壮族和汉族精神分裂症患者基因变异及其与丙戊酸血药浓度的相关性评估
Pharmgenomics Pers Med. 2024 May 14;17:225-236. doi: 10.2147/PGPM.S457805. eCollection 2024.
5
Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.癫痫患儿丙戊酸诱导的血脂异常的治疗前风险预测因素
Front Pharmacol. 2024 Apr 2;15:1349043. doi: 10.3389/fphar.2024.1349043. eCollection 2024.
6
Therapeutic and Toxic Effects of Valproic Acid Metabolites.丙戊酸代谢物的治疗作用与毒性作用
Metabolites. 2023 Jan 16;13(1):134. doi: 10.3390/metabo13010134.
7
Research Progress of Pharmacogenomics in Drug-Induced Liver Injury.药物基因组学在药物性肝损伤中的研究进展
Front Pharmacol. 2021 Sep 6;12:735260. doi: 10.3389/fphar.2021.735260. eCollection 2021.
8
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters.卡马西平和丙戊酸盐的药物遗传学:聚焦于药物代谢酶和转运体的多态性
Pharmaceuticals (Basel). 2021 Mar 1;14(3):204. doi: 10.3390/ph14030204.